December 16, 2020 – Cerner Corporation (Kansas City, MO) announced an agreement to acquire Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment.
Kantar Health is a data, analytics and real-world evidence and commercial research consultancy serving the life science industry.
With this acquisition, Cerner plans to harness data to improve the safety, efficiency and efficacy of clinical research across life sciences, pharmaceuticals and healthcare at large. This acquisition is expected to allow Cerner’s Learning Health Network SM client consortium to more directly engage with life sciences for funded research studies.
The combination of Cerner and Kantar Health is expected to enable a two-sided collaboration between providers and the pharmaceutical industry, where researchers can generate insights and use differentiated real-world data assets and expertise to address the most complex clinical research questions, the company said.
The acquisition is anticipated to close in the first half of 2021, subject to regulatory approval, employee consultations and other conditions, and is not expected to have a material impact on Cerner’s earnings in 2021.